Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis

International Journal of Rheumatic Diseases
Sanket ShahVir Singh Negi

Abstract

Biologics have emerged as an important modality of treatment in rheumatic diseases and have allowed the rheumatologist to explore varied therapeutic uses of these drugs. Rituximab, a monoclonal antibody against CD20 receptor is an important member of the biologic armamentarium for the treatment of various refractory autoimmune inflammatory rheumatic diseases. The drug is now widely used in systemic lupus erythematosus for several complications which are refractory to conventional therapy. Although relatively safe, the post-marketing surveillance of rituximab has revealed a few rare but important adverse reactions. Cytopenia including neutropenia following rituximab, has been vastly reported as a late event (>4 weeks), but a few cases of early onset neutropenia (EON) and thrombocytopenia are also found in the literature. We describe a case of a 35-year-old woman with refractory lupus nephritis who developed asymptomatic EON and thrombocytopenia following rituximab infusion. The neutropenia responded well to granulocyte colony-stimulating factor treatment and the platelets spontaneously recovered. This case report is aimed at highlighting the importance of identifying early onset cytopenia following rituximab which may have an im...Continue Reading

References

Jun 27, 2003·The New England Journal of Medicine·Eric VoogPhilippe Solal-Céligny
Nov 20, 2004·Annals of the Rheumatic Diseases·J-E GottenbergUNKNOWN Club Rheumatismes et Inflammation (CRI)
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M D Pescovitz
Oct 6, 2007·The British Journal of Dermatology·R Rios-FernándezN Ortego-Centeno
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai WengSandra J Horning
Nov 1, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Alina Weissmann-BrennerEsther Rabizadeh
May 24, 2013·European Journal of Clinical Pharmacology·I DanésJ A Bosch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.